Jesse Joachim Swen

60PUBLICATIONS
159CO-AUTHORS
PharmacogenomicsMedical molecular engineering of nucleic acids and proteinsCancer therapy (excl. chemotherapy and radiation therapy)Nanotoxicology, health and safetyHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (60)

|Jul 13, 2026
Design characteristics of mass balance studies conducted for protein kinase inhibitors.

|Jul 12, 2026
UGT1A1 and irinotecan: Ready for routine pharmacogenetic care.

|Jun 08, 2026
Pharmacokinetics of 5-Fluorouracil in Patients Treated With Capecitabine Carrying the c.1236G>A DPYD Variant Allele.

|May 28, 2026
From evidence to implementation: key priorities for pharmacogenomics-guided treatment and prevention from a European expert workshop.

|Mar 02, 2026
Inflammation-driven variability in drug metabolism: Insights from voriconazole treatment of HSCT recipients.

Sylvia D Klomp, Martijn L Manson, Henk-Jan Guchelaar

|Jan 12, 2026
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6 and CYP2C19 and tricyclic antidepressants.

Kristian Kleine Schaars, Marga Nijenhuis, Bianca Soree

Pageof 10

Frequent Collaborators

21 joint publications

Henk-Jan Guchelaar

11 joint publications

Marga Nijenhuis

11 joint publications

Elisa J F Houwink

9 joint publications

Roos van Westrhenen